Switzerland· 54159002
Edronax, Tabletten 4 mg
A reboxetine product, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category B. The same ATC class is registered in 8 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Reboxetine is registered in 8 of 19 countries.
Countries holding a registration under ATC N06AX18 (reboxetine), each read from that country’s own register.
- This record: Switzerland
- 5 of them publish a price we can compare per daily dose
Reboxetine · ATC N06AX18
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of reboxetine costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $1.04 in Italy to $2.27 in Switzerland — a ×2.2 gap.
- Switzerland: $2.27 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Reboxetine · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.27
- IT Italy$1.04
The record
At a glance
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- N06AX18
- ATC class
- Reboxetine
- Defined daily dose
- 8 mg, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for reboxetine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Reboxetine · interactions on record
19 records
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06AX18
Reboxetine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d458bda0-e48a-44d0-8c7f-8dfa153db962 GET /v1/drugs/d458bda0-e48a-44d0-8c7f-8dfa153db962?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about reboxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.